Related Experiment Video
Updated: Mar 2, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Somatization in Parkinson's Disease: A systematic review
Danilo Carrozzino1, Per Bech2, Chiara Patierno3
1Psychiatric Research Unit, Psychiatric Centre North Zealand, Copenhagen University Hospital, Hillerød, Denmark; Department of Psychological, Health, and Territorial Sciences, University "G. d'Annunzio" of Chieti-Pescara, Chieti, Italy.
Somatization is common in Parkinson's Disease (PD), impacting cognitive decline. Further research is needed to understand its clinical effects and refine diagnostic approaches for this psychiatric symptom.
Area of Science:
- Neurology
- Psychiatry
- Psychosomatic Medicine
Background:
- Parkinson's Disease (PD) is a neurodegenerative disorder.
- Somatization, the expression of psychological distress through physical symptoms, is increasingly recognized in PD.
- Understanding the clinimetric implications of somatization in PD is crucial for patient care.
Purpose of the Study:
- To systematically review and critically analyze the clinimetric viewpoint of somatization's clinical consequence in Parkinson's Disease.
- To evaluate the prevalence and impact of somatization on cognitive function in PD patients.
Main Methods:
- Systematic literature review adhering to PRISMA guidelines.
- Comprehensive search across major scientific databases (e.g., PubMed, Scopus, Web of Science).
- Analysis of 9 relevant studies identified from an initial pool of 2,926 records.
Main Results:
- The prevalence of somatization in Parkinson's Disease ranges widely from 7.0% to 66.7%.
- Somatoform disorders significantly predict progressive cognitive impairment in PD patients.
- Somatization is a highly prevalent comorbidity in Parkinson's Disease.
Conclusions:
- Somatization is a significant and prevalent comorbidity in Parkinson's Disease.
- The clinical impact of somatization in PD warrants further investigation.
- Consideration of the psychosomatic concept of persistent somatization (DCPR) is recommended over 'psychogenic parkinsonism'.
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Neural Regulation
Positive Symptoms of Schizophrenia: Hallucinations and Delusions
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes...
Lysosomal Hydrolases

